Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients

被引:0
|
作者
Felipe Kazmirczak
Prabhjot S. Nijjar
Lei Zhang
Andrew Hughes
Ko-Hsuan Amy Chen
Osama Okasha
Cindy M. Martin
Mehmet Akçakaya
Afshin Farzaneh-Far
Chetan Shenoy
机构
[1] University of Minnesota Medical Center,Cardiovascular Division, Department of Medicine
[2] University of Minnesota,Clinical and Translational Science Institute
[3] University of Minnesota Medical School,Department of Electrical and Computer Engineering and Center for Magnetic Resonance Research
[4] University of Minnesota,Division of Cardiology, Department of Medicine
[5] University of Illinois at Chicago,undefined
关键词
Cardiovascular magnetic resonance; Stress perfusion; Vasodilator; Regadenoson; Safety;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Safety and incremental prognostic value of stress cardiovascular magnetic resonance in patients with known chronic kidney disease
    Pezel, Theo
    Unterseeh, Thierry
    Hovasse, Thomas
    Sanguineti, Francesca
    Garot, Philippe
    Champagne, Stephane
    Toupin, Solenn
    Ah-Sing, Tania
    Faradji, Alyssa
    Nicol, Martin
    Hamzi, Lounis
    Dillinger, Jean Guillaume
    Henry, Patrick
    Bousson, Valerie
    Garot, Jerome
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2023, 25 (01)
  • [22] Prognostic value of contrast stress echocardiography, myocardial stress scintigraphy and their combination in heart transplant recipients
    Jung, PH
    Kung, M
    Spes, CH
    Stoerk, S
    Rieber, J
    Koenig, A
    Angermann, CE
    EUROPEAN HEART JOURNAL, 2002, 23 : 452 - 452
  • [23] Incremental prognostic value of contrast-enhanced dobutamine stress echocardiography in the prediction of cardiovascular outcome in heart transplant recipients
    Kung, M
    Störk, S
    Jung, P
    Spes, C
    Angermann, CE
    CIRCULATION, 2004, 110 (17) : 512 - 512
  • [24] Prognostic Value and Natural History of Cardiovascular Magnetic Resonance Derived Myocardial Extracellular Volume in Heart Transplant Patients
    Abbasi, Muhannad
    Sarnari, Roberto
    Chaikriangkrai, Kongkiat
    Khan, Sadiya S.
    Ghafourian, Kambiz
    Wilcox, Jane E.
    Vorovich, Esther
    Lee, Daniel
    Rich, Jonathan
    Anderson, Allen S.
    Yancy, Clyde W.
    Carr, James C.
    Markl, Michael
    CIRCULATION, 2019, 140
  • [25] Prognostic value of invasive investigations in heart transplant recipients
    Wellnhofer, E
    Hiemann, NE
    Hug, J
    Meyer, R
    Dandel, M
    Lehmkuhl, HB
    Hetzer, R
    Fleck, E
    EUROPEAN HEART JOURNAL, 2004, 25 : 581 - 581
  • [26] Prognostic value of invasive investigations in heart transplant recipients
    Wellnhofer, E
    Hiemann, NE
    Hug, J
    Dandel, M
    Girke, F
    Meyer, R
    CIRCULATION, 2003, 108 (17) : 546 - 546
  • [27] Safety and feasibility of dobutamine stress myocardial perfusion imaging in heart transplant recipients
    Elhendy, A
    van Trimpont, P
    Roelandt, T
    van Domburg, R
    Balk, A
    EUROPEAN HEART JOURNAL, 2000, 21 : 89 - 89
  • [28] SAFETY OF CARDIOVASCULAR MAGNETIC RESONANCE REGADENOSON STRESS IMAGING WITHOUT PRE- AND POST-TEST 12-LEAD ELECTROCARDIOGRAPHY
    Hall, M. E.
    Rushing, M.
    Kamimura, D.
    Howard, C.
    Miller, K.
    McMullan, M. R.
    Campbell, W. F.
    Guild, C. S.
    Winniford, M. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 622 - 622
  • [29] Regadenoson in heart transplant recipients: Use without worries
    Mouaz H. Al-Mallah
    Journal of Nuclear Cardiology, 2020, 27 : 949 - 951
  • [30] Regadenoson in heart transplant recipients: Use without worries
    Al-Mallah, Mouaz H.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (03) : 949 - 951